Keyuan Pharmaceutical: Independent Director Candidate Statement and Commitment (Ge Yongbo)
Keyuan Pharmaceutical: Independent Director Candidate Statement and Commitment (Zheng Haiying)
Keyuan Pharmaceutical: Independent Director Nominee Statement and Commitment (Zheng Haiying)
Keyuan Pharmaceutical: Independent Director Nominee Statement and Commitment (Dai Huiyu)
Keyuan Pharmaceutical: Announcement of Resolutions of the 15th Meeting of the Third Board of Supervisors
Keyuan Pharmaceutical: Independent Director Nominee Statement and Commitment (Ge Yongbo)
Keyuan Pharmaceutical: Announcement of Resolutions of the 18th Meeting of the Third Board of Directors
Keyuan Pharmaceutical: Independent Director Candidate Statement and Commitment (Dai Huiyu)
Keyuan Pharmaceutical: CITIC Construction Investment Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Shandong Keyuan Pharmaceutical Co., Ltd.
Shandong Keyuan Pharmaceutical: Special report on the use and placement of funds raised during the first half of 2024.
Shandong Keyuan Pharmaceutical: Announcement of the Supervisory Board's resolution.
Shandong Keyuan Pharmaceutical: Board of directors resolution announcement.
Shandong Keyuan Pharmaceutical: Announcement About Cancellation of Some Raised Funds Special Account.
Shandong Keyuan Pharmaceutical: Announcement of Resolutions of the 16th Meeting of the Third Board of Directors
Keyuan Pharmaceutical: Deheng Shanghai Law Firm's Testimony on the 2023 Annual General Meeting of Shareholders of Shandong Keyuan Pharmaceutical Co., Ltd.
Keyuan Pharmaceutical: CITIC Construction Investment Securities Co., Ltd.'s 2023 follow-up report on Shandong Keyuan Pharmaceutical Co., Ltd.
Keyuan Pharmaceutical: CITIC Construction Investment Securities Co., Ltd.'s inspection opinions on the lifting of the ban and listing and circulation of some restricted shares of Shandong Keyuan Pharmaceutical Co., Ltd. before the initial public offering
Keyuan Pharmaceutical: CITIC Construction Investment Securities Co., Ltd.'s 2023 regular on-site inspection report on Shandong Keyuan Pharmaceutical Co., Ltd.
Keyuan Pharmaceutical: 301281 Keyuan Pharmaceutical Investor Relations Management Information 20240402
Keyuan Pharmaceutical: Announcement of Board Resolutions
No Data
No Data